Apocrine variant of intraductal carcinoma of the parotid gland with sebaceous-like differentiation: expanding morphological and molecular spectrum of an enigmatic entity
Status Publisher Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
PubMed
39443384
DOI
10.1007/s00428-024-03947-w
PII: 10.1007/s00428-024-03947-w
Knihovny.cz E-zdroje
- Klíčová slova
- AKT1 mutation, BRAF V600E mutation, Apocrine intraductal carcinoma, Foamy cell, Salivary, Sebaceous-like differentiation,
- Publikační typ
- časopisecké články MeSH
Intraductal carcinoma (IDC) is a rare tumor of the salivary glands. Here, we report a unique case of apocrine IDC of the parotid gland of a 60-year-old male, exhibiting a striking sebaceous-like differentiation. Microscopically, the tumor displayed a papillary growth pattern with apocrine cells (AR-positive; S100/SOX10-negative) and distinct areas harboring clear, vacuolated cells resembling sebaceous cells (CK7/S100/SOX10-positive; AR negative). Molecular genetic analysis revealed mutations in AKT1 and BRAF genes. An AKT1 gene mutation has earlier been described in sclerosing polycystic adenoma (SPA), suggesting a possible link between IDC and SPA, while BRAF V600E mutations were reported in an oncocytic subtype of IDC, but not in the apocrine one. Since IDC is an indolent disease, its recognition is a key to prevent unwarranted overtreatment. Further evidence is needed to determine whether apocrine IDC with sebaceous-like differentiation represents a novel morphological variant of the apocrine subtype of IDC or a novel salivary gland entity.
Bioptic Laboratory Ltd Pilsen Czech Republic
Department of Pathology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic
Department of Pathology IRCCS Ospedale Policlinico San Martino Genoa Italy
Department of Pathology ULS Gaia e Espinho Vila Nova de Gaia Portugal
Zobrazit více v PubMed
Delgado R, Klimstra D (1996) Albores-Saavedra J. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer 78(5):958z-67. https://doi.org/10.1002/(SICI)1097-0142(19960901)78:5<958::AID-CNCR4>3.0.CO;2-8
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (2017) WHO classification of head and neck tumours. WHO classification of tumours, 4th Edn, Vol 9. ISBN-13, 978-92-832-2438-9
Rooper LM, Thompson LDR, Gagan J, Oliai BR, Weinreb I, Bishop JA (2021) Salivary intraductal carcinoma arising within intraparotid lymph node: a report of 4 cases with identification of a novel STRN-ALK fusion. Head Neck Pathol 15(1):179–185. https://doi.org/10.1007/s12105-020-01198-0 PubMed DOI
Kuo YJ, Weinreb I, Perez-Ordonez B (2013) Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature. Head Neck Pathol 7 Suppl 1(Suppl 1):S59–67. https://doi.org/10.1007/s12105-013-0460-1
Bishop J, Thompson L, Agaimy A, Nagao T, Weinreb I (2023) Intraductal carcinoma. In: WHO classification of tumors editorial board. Head and neck tumors, 5th edn. (WHO classification of tumors series, vol 9). International Agency for Research on Cancer, Lyon. https://publications.iarc.who.int/629 . Accessed Jul 2024
Palicelli A (2020) Intraductal carcinomas of the salivary glands: systematic review and classification of 93 published cases. APMIS 128(3):191–200. https://doi.org/10.1111/apm.13009 PubMed DOI
Russo D, Di Crescenzo RM, Varricchio S, Broggi G, Bizzoca ME, Troise S, Salzano G, Ilardi G, Merolla F (2021) Low-grade intraductal carcinoma of the parotid gland: a case report and literature review. Head Neck Pathol 15(4):1359–1371. https://doi.org/10.1007/s12105-021-01290-z PubMed DOI PMC
Bishop JA, Gagan J, Krane JF, Jo VY (2020) Low-grade apocrine intraductal carcinoma: expanding the morphologic and molecular spectrum of an enigmatic salivary gland tumor. Head Neck Pathol 14(4):869–875. https://doi.org/10.1007/s12105-020-01128-0 PubMed DOI PMC
Gnepp DR (2012) My journey into the world of salivary gland sebaceous neoplasms. Head Neck Pathol 6(1):101–110. https://doi.org/10.1007/s12105-012-0343-x PubMed DOI PMC
Nagao T, Sato E, Inoue R, Oshiro H, Reisuke H, Takahashi R, Nagai T, Yoshida M, Suzuki F, Obikane H, Yamashina M, Matsubayashi J (2012) Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem 45(5):269–82. https://doi.org/10.1267/ahc.12019 PubMed DOI PMC
Freiberger SN, Brada M, Fritz C, Höller S, Vogetseder A, Horcic M, Bihl M, Michal M, Lanzer M, Wartenberg M, Borner U, Bode PK, Broglie MA, Rordorf T, Morand GB, Rupp NJ (2021) SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets. Neoplasia 23(5):473–487. https://doi.org/10.1016/j.neo.2021.03.008 PubMed DOI PMC
Skálová A, Baněčková M, Laco J, Di Palma S, Agaimy A, Ptáková N, Costes-Martineau V, Petersson BF, van den Hout MFCM, de Rezende G, Klubíčková N, Koblížek M, Koshyk O, Vaneček T, Leivo I (2022) Sclerosing polycystic adenoma of salivary glands: a novel neoplasm characterized by PI3K-AKT pathway alterations-new insights into a challenging entity. Am J Surg Pathol 46(2):268–280. https://doi.org/10.1097/PAS.0000000000001807 PubMed DOI
Bishop JA, Gagan J, Baumhoer D, McLean-Holden AL, Oliai BR, Couce M, Thompson LDR (2020) Sclerosing polycystic “adenosis” of salivary glands: a neoplasm characterized by PI3K pathway alterations more correctly named sclerosing polycystic adenoma. Head Neck Pathol 14(3):630–636. https://doi.org/10.1007/s12105-019-01088-0 PubMed DOI
Bishop J, Thompson L, Prasad M, Petterson B, Losito N (2023) Sclerosing polycystic adenoma. In: WHO classification of tumors editorial board. Head and neck tumors. International Agency for Research on Cancer, Lyon. (WHO classification of tumors series, 5th edn, vol. 9). https://publications.iarc.who.int/629 . Accessed July 2024
Bishop JA, Nakaguro M, Whaley RD, Ogura K, Imai H, Laklouk I, Faquin WC, Sadow PM, Gagan J, Nagao T (2021) Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations. Histopathology 79(3):338–346. https://doi.org/10.1111/his.14296 PubMed DOI PMC